Search
Patexia Research
Case number 2:18-cv-00124

Indivior et al v. Actavis Laboratories UT > Documents

Date Field Doc. No.Description (Pages)
Jul 9, 2020 19 Motion to Continue (3)
Jul 9, 2020 16 Motion for Extension of Time to File Answer (3)
Jul 9, 2020 13 Motion for Extension of Time to File Answer (3)
Jul 9, 2020 7 Motion for Extension of Time to File Answer (3)
May 3, 2018 N/A Terminated Case (0)
Docket Text: Civil Case Terminated per [20] Notice of Voluntary Dismissal. (las)
May 3, 2018 21 Report Regarding Patent and Trademark (1)
Docket Text: Report on the Final Decision of an action sent to the Director of the U.S. Patent and Trademark Office. (las)
May 2, 2018 20 Main Document (2)
Docket Text: NOTICE of Voluntary Dismissal filed by Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited (Attachments: # (1) Text of Proposed Order proposed Order) (Berger, Arthur)
May 2, 2018 20 Notice of Voluntary Dismissal (2)
May 2, 2018 20 Text of Proposed Order proposed Order (2)
Apr 19, 2018 19 Main Document (3)
Docket Text: Stipulated MOTION to Continue the Initial Pretrial Conference filed by Defendant Actavis Laboratories UT. (Attachments: # (1) Text of Proposed Order Proposed Order Granting Stipulation and Joint Motion to Reschedule the Initial Pretrial Conference)(Gehret, Michael)
Apr 19, 2018 19 Text of Proposed Order Proposed Order Granting Stipulation and Joint Motion to R (2)
Apr 18, 2018 18 Order on Motion for Extension of Time to Answer (1)
Docket Text:ORDER granting [16] Motion for Extension of Time to Answer re [2] Complaint. Answer deadline updated for Actavis Laboratories UT answer due 5/3/2018. Signed by Magistrate Judge Dustin B. Pead on 4/18/2018. (las)
Apr 17, 2018 16 Main Document (3)
Docket Text: Stipulated MOTION for Extension of Time to File Answer re [2] Complaint, filed by Defendant Actavis Laboratories UT. (Attachments: # (1) Text of Proposed Order Order Granting Stipulated MOtion for Extension of Time)(Gehret, Michael)
Apr 17, 2018 16 Text of Proposed Order Order Granting Stipulated MOtion for Extension of Time (2)
Apr 17, 2018 N/A Received Consent to US Magistrate Judge Form (0)
Docket Text: RECEIVED Consent/Reassignment Form from Defendant Actavis Laboratories UT. (las)
Apr 16, 2018 15 Notice of Presiding Magistrate Assignment Reminder (1)
Docket Text: NOTICE REMINDER - All parties are requested to respond within the time frame set forth in the [10] Notice of Presiding Magistrate Assignment,, pursuant to General Order 07-001. If you have already consented/objected, please disregard this notice. No judge will be informed of a party's response unless all parties have consented to the assignment of the matter to a U.S. Magistrate Judge. Unless consents from all parties are received within fifteen(15) days, the case will be randomly re-assigned to a U.S. District Judge without further notice.
Link to Magistrate Consent Objection form (las)
Apr 4, 2018 14 Order on Motion for Extension of Time to Answer (1)
Docket Text:ORDER granting [13] Motion for Extension of Time to Answer re [2] Complaint. Answer deadline updated for Actavis Laboratories UT answer due 4/19/2018. Signed by Magistrate Judge Dustin B. Pead on 4/4/2018. (las)
Apr 3, 2018 13 Text of Proposed Order Proposed Order Granting Stipulated Motion for Extention o (2)
Apr 3, 2018 13 Main Document (3)
Docket Text: Stipulated MOTION for Extension of Time to File Answer re [2] Complaint, filed by Defendant Actavis Laboratories UT. (Attachments: # (1) Text of Proposed Order Proposed Order Granting Stipulated Motion for Extention of Time)(Gehret, Michael)
Apr 2, 2018 N/A Notice of Hearing (0)
Docket Text:NOTICE OF INITIAL PRETRIAL CONFERENCE:: (Notice generated by IPT Clerk)

The Attorneys Planning Meeting Report and Proposed Scheduling Order forms, available on the court web site at http://www.utd.uscourts.gov/usdc-forms, should be prepared 21 days before the Initial Pretrial Conference hearing date.

NOTICE TO COUNSEL, The Court may enter a scheduling order and vacate the hearing if counsel

(a) file a stipulated Attorneys Planning Meeting Report; and

(b) e-mail a Proposed Scheduling Order to ipt@utd.uscourts.gov

21 days before the scheduled hearing. See instructions at http://www.utd.uscourts.gov/attorney-planning-meeting-and-report

If counsel or the parties would like to participate by phone they must contact the IPT Clerk at least two days in advance at ipt@utd.uscourts.gov to make arrangements.

Initial Pretrial Conference set for 5/9/2018 at 11:00 AM in Rm 7.400 before Magistrate Judge Evelyn J. Furse. (jds)
Mar 29, 2018 8 Notice of ADR (1)
Docket Text: NOTICE OF ADR, e-mailed or mailed to Defendant Actavis Laboratories UT, Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited. (las)
Mar 29, 2018 N/A Notice From the Court re Initial Scheduling (0)
Docket Text: NOTICE FROM THE COURT re: Initial Scheduling
The court's IPT Clerk will now set the case for the Initial Pretrial Scheduling Conference (las)
Mar 29, 2018 10 Notice of Presiding Magistrate Assignment (1)
Docket Text: NOTICE - This case is assigned to a magistrate judge. To consent or request reassignment, use the form on this link or use the included form for non-efilers and send it to
consents@utd.uscourts.gov
within 15 days or mail to the court with Attention: Consent Clerk on the envelope. Notice e-mailed or mailed to Defendant Actavis Laboratories UT, Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited. Form due by 4/13/2018. (las)
Mar 29, 2018 11 Order on Motion for Extension of Time to Answer (1)
Docket Text:ORDER granting [7] Motion for Extension of Time to Answer re [2] Complaint. Answer deadline updated for Actavis Laboratories UT answer due 4/5/2018. Signed by Magistrate Judge Dustin B. Pead on 3/29/2018. (las)
Mar 28, 2018 7 Text of Proposed Order Proposed Order Granting Stipulated Motion for Extension o (2)
Mar 28, 2018 7 Main Document (3)
Docket Text: Stipulated MOTION for Extension of Time to File Answer re [2] Complaint, filed by Defendant Actavis Laboratories UT. (Attachments: # (1) Text of Proposed Order Proposed Order Granting Stipulated Motion for Extension of Time) Attorney Michael A. Gehret added to party Actavis Laboratories UT(pty:dft)(Gehret, Michael)
Feb 8, 2018 4 Rule 7 Corporate Disclosure Statement (3)
Docket Text: CORPORATE DISCLOSURE STATEMENT under FRCP 7.1 filed by Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited identifying Indivior Finance LLC as Corporate Parent. (Berger, Arthur)
Feb 7, 2018 2 Complaint (7)
Feb 7, 2018 2 Main Document (7)
Docket Text: COMPLAINT against Actavis Laboratories UT (Filing fee $ 400, receipt number 1088-2935499) filed by Indivior UK Limited, Indivior, Aquestive Therapeutics. (Attachments: # (1) Exhibit A-US 9,855,221, # (2) Civil Cover Sheet Cover Sheet) Assigned to Magistrate Judge Dustin B. Pead (Berger, Arthur)
Feb 7, 2018 1 Remark - New Case (1)
Docket Text: Case has been indexed and assigned to Magistrate Judge Dustin B. Pead. Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited is directed to E-File the Complaint and cover sheet (found under Complaints and Other Initiating Documents) and pay the filing fee of $ 400.00 by the end of the business day.
NOTE: The court will not have jurisdiction until the opening document is electronically filed and the filing fee paid in the CM/ECF system.
Civil Summons may be issued electronically. Prepare the summons using the courts PDF version and email it to utdecf_clerk@utd.uscourts.gov for issuance. (nl)
Feb 7, 2018 3 Report Regarding Patent and Trademark (1)
Docket Text: Report on the Filing of an action sent to the Director of the U.S. Patent and Trademark Office. (nl)
Feb 7, 2018 2 Civil Cover Sheet Cover Sheet (1)
Feb 7, 2018 2 Exhibit A-US 9,855,221 (36)
Feb 7, 2018 2 Complaint* (1)
Menu